Groove Botanicals INC. (GRVE) — SEC Filings

Overview

Groove Botanicals INC. (GRVE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 19, 2025: GROOVE BOTANICALS INC. (GRVE) reported a net loss of $70,553 for the six months ended September 30, 2025, an increase from a net loss of $66,372 for the same period in 2024. The company's total assets increased to $8,164 as of September 30, 2025, from $4,520 as of March 31, 2025, primarily due to an

Sentiment Summary

Across 14 filings, the sentiment breakdown is: 3 bearish, 11 neutral. The dominant filing sentiment for Groove Botanicals INC. is neutral.

Filing Type Overview

Groove Botanicals INC. (GRVE) has filed 7 10-Q, 2 10-K/A, 2 10-K, 3 8-K with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (14)

• Groove Botanicals' Losses Mount Amid EV Battery Pivot, No Revenue — 10-Q · Nov 19, 2025 Risk: high
  GROOVE BOTANICALS INC. (GRVE) reported a net loss of $70,553 for the six months ended September 30, 2025, an increase from a net loss of $66,372 for the same pe
• Groove Botanicals Amends 10-K/A for Typos, EV Battery Ambitions Unchanged — 10-K/A · Aug 25, 2025 Risk: high
  GROOVE BOTANICALS INC. (GRVE) filed a 10-K/A Amendment No. 2 for the fiscal year ended March 31, 2025, solely to correct typographical errors in the Report of I
• Groove Botanicals Files 10-Q for Q2 2025 — 10-Q · Aug 19, 2025 Risk: low
  Groove Botanicals Inc. filed its 10-Q for the period ending June 30, 2025. The company, formerly known as Avalon Oil & Gas, Inc., is listed under the SIC code f
• Groove Botanicals Files 10-K/A Amendment — 10-K/A · Aug 15, 2025 Risk: medium
  Groove Botanicals Inc. filed an amendment (10-K/A) on August 15, 2025, for the fiscal year ending March 31, 2025. The company, formerly Avalon Oil & Gas, Inc.,
• GROOVE BOTANICALS' Losses Double Amid Leadership Change — 10-K · Jul 16, 2025 Risk: high
  GROOVE BOTANICALS INC. (GRVE) reported a net loss of $1,000,000 for the fiscal year ended March 31, 2025, a significant increase from the $500,000 net loss in t
• Groove Botanicals Files Q3 2024 10-Q — 10-Q · Feb 25, 2025 Risk: medium
  Groove Botanicals Inc. filed its 10-Q for the period ending December 31, 2024. The company, formerly Avalon Oil & Gas, Inc., is in the Crude Petroleum & Natural
• Groove Botanicals Files 10-Q, Details Preferred Stock — 10-Q · Nov 14, 2024 Risk: medium
  Groove Botanicals Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Avalon Oil & Gas, Inc., is listed under the Crude Petroleu
• Groove Botanicals Inc. Files 10-Q, Shows Financial Snapshot — 10-Q · Aug 22, 2024 Risk: medium
  Groove Botanicals Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly Avalon Oil & Gas, Inc., is classified under Crude Petroleum & N
• Groove Botanicals Files 2024 Annual Report — 10-K · Aug 15, 2024 Risk: low
  Groove Botanicals Inc. filed its 10-K for the fiscal year ended March 31, 2024, reporting on its operations. The company, formerly known as Avalon Oil & Gas, In
• Groove Botanicals Inc. Files 8-K for Officer Changes — 8-K · Aug 1, 2024 Risk: low
  Groove Botanicals Inc. filed an 8-K on July 29, 2024, reporting changes in directors and officers, and the appointment of certain officers. The filing also incl
• Groove Botanicals Inc. Changes Certifying Accountant — 8-K · Jun 26, 2024 Risk: medium
  Groove Botanicals Inc. filed an 8-K on June 26, 2024, reporting a change in its certifying accountant. The company, formerly known as Avalon Oil & Gas, Inc., ha
• Groove Botanicals Changes Certifying Accountant to BDO USA — 8-K · May 10, 2024 Risk: low
  Groove Botanicals Inc. announced on May 8, 2024, that it has changed its certifying accountant to BDO USA, P.A. This change follows the resignation of its previ
• Groove Botanicals Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 14, 2024 Risk: low
  GROOVE BOTANICALS INC. (GRVE) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. Groove Botanicals Inc. filed a 10-Q report for the period endin
• Groove Botanicals Inc. Files 10-Q for Period Ending September 30, 2023 — 10-Q · Jan 11, 2024 Risk: low
  GROOVE BOTANICALS INC. (GRVE) filed a Quarterly Report (10-Q) with the SEC on January 11, 2024. Groove Botanicals Inc. filed a 10-Q report for the period ending

Risk Profile

Risk Assessment: Of GRVE's 14 recent filings, 3 were flagged as high-risk, 5 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Groove Botanicals INC.'s most recent 10-Q filing (Nov 19, 2025):

• Revenue: $0
• Net Income: -$70,553
• EPS: $0.00
• Debt-to-Equity: N/A
• Cash Position: $1,492
• Operating Margin: N/A
• Total Assets: $8,164
• Total Debt: $1,297,813

Key Executives

• Kent Rodriguez
• Donald Trump
• Michael C. Anderson

Industry Context

The company is attempting to pivot into the early-stage EV Battery Technologies sector. This is a rapidly growing but highly competitive industry, dominated by established players and requiring significant R&D investment and intellectual property. Success hinges on technological breakthroughs and securing substantial funding.

Top Tags

10-Q (6) · financials (5) · oil-gas (3) · oil-and-gas (3) · SEC Filing (3) · Net Loss (2) · EV Battery Technology (2) · No Revenue (2) · High Risk Investment (2) · preferred-stock (2)

Key Numbers

• Net Loss: $70,553 — for the six months ended September 30, 2025, an increase from $66,372 in 2024
• Accumulated Deficit: $35,376,369 — as of September 30, 2025, indicating significant historical losses
• Cash: $1,492 — as of September 30, 2025, a decrease from $2,042 at March 31, 2025
• Total Current Liabilities: $1,297,813 — as of September 30, 2025, up from $1,114,381 at March 31, 2025
• Related Party Payable: $687,957 — as of September 30, 2025, an increase from $608,833 at March 31, 2025
• Common Shares Outstanding: 59,643,062 — as of November 18, 2025
• CEO Annual Salary: $48,000 — accrued wages payable to Kent Rodriguez
• Preferred Dividends to Related Party: $20,000 — accrued for Series A preferred shares for six months ended September 30, 2025
• Series A Preferred Conversion Ratio: 0.51% — each share converts to 0.51% of fully-diluted common stock
• Total Assets: $8,164 — as of September 30, 2025, up from $4,520 at March 31, 2025
• Aggregate market value of common stock held by non-affiliates: $709,689 — As of September 30, 2024, indicating a small market capitalization.
• Shares of Common Stock outstanding: 59,643,062 — As of June 30, 2025.
• Par value per share of Common Stock: $0.001 — Indicates a low nominal value per share.
• Minimum anticipated capital needs: $500,000 — For business development and asset acquisitions.
• Maximum anticipated capital needs: $5,000,000 — For business development and asset acquisitions, varying based on growth strategies.

Frequently Asked Questions